- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- Analysis
- Focus Articles
- Related Articles
- Instablogs1 new
- StockTalks
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
JNJ Market Currents
more »
-
Friday 8:58 AM At the top of Goldman Sachs' VIP List of 50 stocks most important to hedge funds is Apple (AAPL), followed by GOOG, ESRX, MSFT, QCOM, C, GM, PCLN, JPM and LMCA. Leading the list of the firm's top 50 short positions is JNJ, XOM, INTC, IBM, AMZN, T, CVX, VZ, DUK and DIS.
11 Comments[Quick Ideas]
- Wednesday 5:38 PM An FDA advisory panel recommends against approval of Johnson & Johnson's (JNJ) Xarelto blood thinner to reduce life-threatening blood clots. JNJ already markets the pill to treat irregular heartbeat and patients undergoing hip or knee replacement surgery. [Healthcare]
- Monday 8:59 AM J&J's (JNJ +0.2%) blood thinner Xarelto seems to cut the risk of new heart attacks and strokes in people with cardiac problems, the FDA says in a review, although missing data raises doubts that the treatment actually works. An FDA advisory panel is due to vote on Wednesday on whether to recommend the drug. [Healthcare]
JNJ in Focus
more »
JNJ Related Articles
more »
JNJ News
more »
-
at MarketWatch.com (Fri, 9:57AM)
-
at CNBC.com (Thu, 7:43AM)
-
at CNBC.com (Wed, 4:52PM)
-
at MarketWatch.com (Tue, 12:01AM)
-
at CNBC.com (May 17, 2012)
JNJ Press Releases and Filings
more »
-
PR Newswire (Fri, 8:30AM)
-
Business Wire (May 11, 2012)
-
Biosense Webster Collaborates to Bring Innovative Solutions to Electrophysiologists Around the WorldBusiness Wire (May 9, 2012)
-
PR Newswire (May 3, 2012)
-
PR Newswire (May 2, 2012)
JNJ Latest Transcript
more »
-
Thu, Apr 26
JNJ Cramer
more »
JNJ Instablog posts
more »
JNJ vs. ETF Alternatives
Company Description
General
Johnson & Johnson and its subsidiaries have approximately 115,500 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. Johnson & Johnson is a holding company, which has more than 250 operating... More
